Highlights and Quick Summary
- Non-operating Interest Expenses for the quarter ending September 30, 2022 was $3.04 Million (a 125.78% increase compared to previous quarter)
- Year-over-year quarterly Non-operating Interest Expenses increased by 103.14%
- Annual Non-operating Interest Expenses for 2021 was $4.51 Million (a -40.72% decrease from previous year)
- Annual Non-operating Interest Expenses for 2020 was $7.6 Million (a 152.79% increase from previous year)
- Annual Non-operating Interest Expenses for 2019 was $3.01 Million (a 12433.33% increase from previous year)
- Twelve month Non-operating Interest Expenses ending September 30, 2022 was $7.02 Million (a 27.02% increase compared to previous quarter)
- Twelve month trailing Non-operating Interest Expenses increased by 55.68% year-over-year
Trailing Non-operating Interest Expenses for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| $7.02 Million | $5.53 Million | $4.99 Million | $4.51 Million |
Visit stockrow.com/BDSX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Non-operating Interest Expenses of Biodesix, Inc.
Most recent Non-operating Interest Expensesof BDSX including historical data for past 10 years.Interactive Chart of Non-operating Interest Expenses of Biodesix, Inc.
Biodesix, Inc. Non-operating Interest Expenses for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $3.04 | $1.35 | $1.14 | – |
| 2021 | $1.5 | $1.55 | $0.82 | $0.65 | $4.51 |
| 2020 | $0.71 | $2.66 | $2.78 | $1.46 | $7.6 |
| 2019 | – | – | $0.06 | $0.71 | $3.01 |
| 2018 | – | – | – | – | $0.02 |
Business Profile of Biodesix, Inc.
Sector: Healthcare
Industry: Diagnostics & Research